Sandra S.H. Lui

Statistics

Publications

Citations

316

H-Index

Active since

2010

Affiliations

Chinese University of Hong Kong(Current)

Prince of Wales Hospital

Sandra S.H. Lui is an author at Chinese University of Hong Kong specializing in pharmacogenetics, pharmacogenomics, and pharmacogenetics of lipid-lowering therapy.

Publications per year

2010–2013

Publications

ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin

Brian Tomlinson, Ming Hu, Vivian Lee et al. · Clinical Pharmacology & Therapeutics · 2010 · 142 citations

Medicine, Pharmacokinetics, Pharmacology +17

Effects of Polymorphisms in ABCG2 , SLCO1B1 , SLC10A1 and CYP2C9 / 19 on Plasma Concentrations of Rosuvastatin and Lipid Response in Chinese Patients

Hon-Kit Lee, Miao Hu, Sandra S.H. Lui et al. · Pharmacogenomics · 2013 · 108 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +16

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients

Miao Hu, Sandra S.H. Lui, Valiant W.L. Mak et al. · Pharmacogenetics and Genomics · 2010 · 48 citations

Life Sciences, Genetics, Pharmacology +17

The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin

Miao Hu, Sandra S.H. Lui, Lai‐Shan Tam et al. · Journal of Lipid Research · 2012 · 18 citations · Full text

Life Sciences, Molecular Genetics, Pharmacology +15

1–4 of 4